Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mathieu Robain is active.

Publication


Featured researches published by Mathieu Robain.


BMJ | 2016

Routinely collected data may usefully supplement randomised controlled data on treatment effects for mortality

David Pérol; Mathieu Robain; Suzette Delaloge; Christian Cailliot

Hemkens and colleagues investigated the effects of treatment on mortality in routinely collected data and subsequent randomised trials.1 They found that observational studies with routinely collected data substantially overestimated the effects of treatment, despite the use of propensity scores to address confounding bias. This overestimation might, however, be partially due to the selection of studies. In randomised controlled trials, a pitfall is choosing a control that reflects the realities of medical care, and a major …


Journal of Clinical Oncology | 2016

Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study.

Suzette Delaloge; David Pérol; Etienne Brain; Bernard Asselain; Thomas Bachelot; Marc Debled; V. Dieras; Mario Campone; Christelle Levy; William Jacot; Veronique Lorgis; Corinne Veyret; Florence Dalenc; Jean-Marc Ferrero; Lionel Uwer; Anthony Gonçalves; Irwin Piot; Gaetane Simon; Mathieu Robain; Christian Cailliot


Revue D Epidemiologie Et De Sante Publique | 2017

Données de vraie vie en oncologie. Méthodologie de constitution d’une plateforme de données exhaustives multisources : l’exemple de la base ESME

Tahar Guesmia; C. Courtinard; F. Bachelot; M. Mons; A. Jaffre; A.V. Guizrad; J.P. Bleuse; P. Arveux; E. Chamorey; M. Breton; L. Laborde; D. Parent; David Pérol; Mathieu Robain


Anticancer Research | 2017

First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study

V. Dieras; Simona Pop; Frédérique Berger; Marie-Eglantine Dujaric; Philippe Beuzeboc; Laurence Escalup; François-Clément Bidard; Paul Cottu; Christophe Le Tourneau; Sophie Piperno-Neumann; Valerie Laurence; Mathieu Robain; Bernard Asselain; Jean-Yves Pierga


Innovations & Thérapeutiques en Oncologie | 2016

Programme ESMÉ d’UNICANCER : améliorer la prise en charge des patients à partir des données de vie réelle en cancérologie

Christian Cailliot; Gaetane Simon; Camille Baron; C. Courtinard; Mathieu Robain


European Journal of Cancer | 2018

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Elisa Gobbini; Monia Ezzalfani; V. Dieras; Thomas Bachelot; Etienne Brain; Marc Debled; William Jacot; Marie Ange Mouret-Reynier; Anthony Gonçalves; Florence Dalenc; Anne Patsouris; Jean Marc Ferrero; Christelle Levy; Veronique Lorgis; Laurence Vanlemmens; Claudia Lefeuvre-Plesse; Simone Mathoulin-Pélissier; Thierry Petit; Lionel Uwer; Christelle Jouannaud; Marianne Leheurteur; Magali Lacroix-Triki; Audrey Lardy Cleaud; Mathieu Robain; C. Courtinard; Christian Cailliot; David Pérol; Suzette Delaloge


European Journal of Cancer | 2018

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

E. Jacquet; A. Lardy-Cléaud; B. Pistilli; S. Franck; P. Cottu; Suzette Delaloge; M. Debled; Laurence Vanlemmens; Marianne Leheurteur; A.V. Guizard; L. Laborde; Lionel Uwer; William Jacot; D. Berchery; I. Desmoulins; Jean-Marc Ferrero; G. Perrocheau; C. Courtinard; Etienne Brain; Sylvie Chabaud; Mathieu Robain; Thomas Bachelot


The Breast | 2018

Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME MBC COHORT

Sophie Frank; Corinne Tchokothe; Matthieu Carton; Emmanuelle Mouret-Fourme; Coraline Dubot; Mario Campone; Barbara Pistilli; Florence Dalenc; Audrey Mailliez; Christelle Levy; William Jacot; Marc Debled; Marianne Leheurteur; Claudia Lefeuvre; Anthony Gonçalves; Lionel Uwer; Jean-Marc Ferrero; Jean-Christophe Eymard; Thierry Petit; Marie-Ange Mouret-Reynier; Tahar Guesmia; Thomas Bachelot; Mathieu Robain; Paul Cottu


Revue D Epidemiologie Et De Sante Publique | 2018

Utilisation du score de propension : application aux données ESME, pour évaluer l’activité de l’Eribuline en pratique réelle chez les patients atteints d’un cancer du sein métastatique

J. Fraisse; W. Jacot; A. Lardy-Cleaud; A. Lusque; C. Saint-Martin; Sylvie Chabaud; David Pérol; E. Chamorey; G. Simon; C. Bellerag; L. Campion; M. Ezzalfani; T. Filleron; C. Courtinard; Mathieu Robain; S. Gourgou


Revue D Epidemiologie Et De Sante Publique | 2018

Addressing the issue of bias in observational studies : Instrumental variable & Quasi-trial in ESME Research program

M. Ezzalfani; Suzette Delaloge; R. Porcher; A. Savignoni; C. Courtinard; G. Chenuc; Mathieu Robain; David Pérol

Collaboration


Dive into the Mathieu Robain's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

William Jacot

University of Montpellier

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean-Marc Ferrero

University of Nice Sophia Antipolis

View shared research outputs
Top Co-Authors

Avatar

Marc Debled

University of Bordeaux

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge